Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 18, Issue 18, pp. 5061-5070
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 21, 2012
- Revision received June 19, 2012
- Accepted June 20, 2012
- Published first July 3, 2012.
Article Versions
- Previous version (July 3, 2012 - 08:37).
- Previous version (July 30, 2012 - 09:30).
- You are viewing the most recent version of this article.
Copyright & Usage
©2012 American Association for Cancer Research.
Author Information
- Maarten A. Wildeman1,
- Zlata Novalić3,
- Sandra A.W.M. Verkuijlen3,
- Hedy Juwana3,
- Alwin D.R. Huitema4,
- I. Bing Tan1,
- Jaap M. Middeldorp3,
- Jan Paul de Boer2, and
- Astrid E. Greijer3
- Authors' Affiliations: Departments of 1Head and Neck Oncology and Surgery and 2Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital; 3Department of Pathology, VU University Medical Center; and 4Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands
- Corresponding Author:
Astrid Greijer, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Phone: +31-20-4444052; Fax: +32-20-4442964; E-mail: ae.greijer{at}vumc.nl
September 2012
Volume 18, Issue 18
Volume 18, Issue 18
Cytolytic Virus Activation Therapy for Epstein-Barr Virus–Driven Tumors
Jump to section
Advertisement